Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?

Jing Zhang,1 Chao-Sheng Peng,2,* Yu-Hong Tian3,*1Bachelor of Nursing, Special Medical Department, The Sixth Medical Center of People’s Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People’s Republic of China; 2Special Medical Department, Th...

Full description

Bibliographic Details
Main Authors: Zhang J, Peng CS, Tian YH
Format: Article
Language:English
Published: Dove Medical Press 2019-08-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/primary-site-surgery-for-elderly-patients-with-distant-metastatic-panc-peer-reviewed-article-CIA
_version_ 1818347432949317632
author Zhang J
Peng CS
Tian YH
author_facet Zhang J
Peng CS
Tian YH
author_sort Zhang J
collection DOAJ
description Jing Zhang,1 Chao-Sheng Peng,2,* Yu-Hong Tian3,*1Bachelor of Nursing, Special Medical Department, The Sixth Medical Center of People’s Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People’s Republic of China; 2Special Medical Department, The Sixth Medical Center of People’s Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People’s Republic of China; 3Bachelor of Nursing. Special Medical Department, The Sixth Medical Center of People’s Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People’s Republic of China*These authors contributed equally to this workObjective: To investigate the effect of primary site surgery (PSS) on elderly patients (≥65 years) with pancreatic neuroendocrine tumor (pNET) distant metastasis.Patients and methods: We reviewed Surveillance Epidemiology and the End Results database for elderly patients with distant pNET from 1973 to 2015. The variables and survival outcomes of patients with PSS were compared with that of patients with no PSS. After propensity score matching, the survival outcome was compared again between the two groups. Multivariable Cox proportional hazard model was used to identify variables associated with cancer-specific and overall survival. Four sub-groups were divided according to the age and differentiation: 1) age 65–74 years+ well or moderately differentiated; 2) age ≥75 years+ well or moderately differentiated; 3) age 65–74 years+ poorly differentiated or undifferentiated; and 4) age ≥75 years+ poorly differentiated or undifferentiated. Cancer-specific survival was compared between the patients with and without PSS in the above each group.Results: A total of 210 elderly patients with distant pNET were finally confirmed. Of which, 148 patients did not undergo PSS, while 62 patients underwent PSS. Being female (p=0.049), locating on body/tail of pancreas (p=0.006), and well or moderately differentiated (p=0.032) were more likely received PSS. The patients underwent PSS had better survival outcomes both before and after propensity score matching. Multivariable Cox proportional hazard analysis proves PSS and higher histological grade to be protective and risk factors. PSS may improve cancer specific survival in patients of group 1), and no improvement was observed in patients of the other three sub-groups.Conclusion: Not all elderly patients with pNET distant metastasis could benefit from PSS. Patients aged 65–74 years with well or moderately differentiated may benefit from primary lesion surgery, but should be evaluated carefully. Prospective randomized controlled trials are worth performing.Keywords: primary site surgery, pancreatic neuroendocrine tumor, distant metastasis, elderly patients
first_indexed 2024-12-13T17:34:05Z
format Article
id doaj.art-7aee46e4df144f89a4bb26835f0ab01c
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-12-13T17:34:05Z
publishDate 2019-08-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-7aee46e4df144f89a4bb26835f0ab01c2022-12-21T23:36:59ZengDove Medical PressClinical Interventions in Aging1178-19982019-08-01Volume 141419143247666Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?Zhang JPeng CSTian YHJing Zhang,1 Chao-Sheng Peng,2,* Yu-Hong Tian3,*1Bachelor of Nursing, Special Medical Department, The Sixth Medical Center of People’s Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People’s Republic of China; 2Special Medical Department, The Sixth Medical Center of People’s Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People’s Republic of China; 3Bachelor of Nursing. Special Medical Department, The Sixth Medical Center of People’s Liberation Army General Hospital (The Former Naval General Hospital of PLA), Beijing, People’s Republic of China*These authors contributed equally to this workObjective: To investigate the effect of primary site surgery (PSS) on elderly patients (≥65 years) with pancreatic neuroendocrine tumor (pNET) distant metastasis.Patients and methods: We reviewed Surveillance Epidemiology and the End Results database for elderly patients with distant pNET from 1973 to 2015. The variables and survival outcomes of patients with PSS were compared with that of patients with no PSS. After propensity score matching, the survival outcome was compared again between the two groups. Multivariable Cox proportional hazard model was used to identify variables associated with cancer-specific and overall survival. Four sub-groups were divided according to the age and differentiation: 1) age 65–74 years+ well or moderately differentiated; 2) age ≥75 years+ well or moderately differentiated; 3) age 65–74 years+ poorly differentiated or undifferentiated; and 4) age ≥75 years+ poorly differentiated or undifferentiated. Cancer-specific survival was compared between the patients with and without PSS in the above each group.Results: A total of 210 elderly patients with distant pNET were finally confirmed. Of which, 148 patients did not undergo PSS, while 62 patients underwent PSS. Being female (p=0.049), locating on body/tail of pancreas (p=0.006), and well or moderately differentiated (p=0.032) were more likely received PSS. The patients underwent PSS had better survival outcomes both before and after propensity score matching. Multivariable Cox proportional hazard analysis proves PSS and higher histological grade to be protective and risk factors. PSS may improve cancer specific survival in patients of group 1), and no improvement was observed in patients of the other three sub-groups.Conclusion: Not all elderly patients with pNET distant metastasis could benefit from PSS. Patients aged 65–74 years with well or moderately differentiated may benefit from primary lesion surgery, but should be evaluated carefully. Prospective randomized controlled trials are worth performing.Keywords: primary site surgery, pancreatic neuroendocrine tumor, distant metastasis, elderly patientshttps://www.dovepress.com/primary-site-surgery-for-elderly-patients-with-distant-metastatic-panc-peer-reviewed-article-CIAprimary site surgerypancreatic neuroendocrine tumordistant metastasiselderly patients
spellingShingle Zhang J
Peng CS
Tian YH
Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
Clinical Interventions in Aging
primary site surgery
pancreatic neuroendocrine tumor
distant metastasis
elderly patients
title Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
title_full Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
title_fullStr Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
title_full_unstemmed Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
title_short Primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor: to do or not to do?
title_sort primary site surgery for elderly patients with distant metastatic pancreatic neuroendocrine tumor to do or not to do
topic primary site surgery
pancreatic neuroendocrine tumor
distant metastasis
elderly patients
url https://www.dovepress.com/primary-site-surgery-for-elderly-patients-with-distant-metastatic-panc-peer-reviewed-article-CIA
work_keys_str_mv AT zhangj primarysitesurgeryforelderlypatientswithdistantmetastaticpancreaticneuroendocrinetumortodoornottodo
AT pengcs primarysitesurgeryforelderlypatientswithdistantmetastaticpancreaticneuroendocrinetumortodoornottodo
AT tianyh primarysitesurgeryforelderlypatientswithdistantmetastaticpancreaticneuroendocrinetumortodoornottodo